Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02475031 · ClinicalTrials.gov registry record · Phase 4
Single-shot TAP Block vs Continuous TAP Block
A Phase 4 study of Postoperative Pain, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT02475031 is a Phase 4 study of Postoperative Pain that has completed, run by Indiana University. The registered enrollment target is 70 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02475031, a Phase 4 study of Postoperative Pain, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether continuous transversus abdominis plane (TAP) block is superior to single shot TAP for postoperative pain after laparoscopic donor nephrectomy
Conditions Studied
Interventions
- DEVICE TAP-C
- DRUG TAP-S
Study Locations (1)
Indiana
- Indiana University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02475031
The ClinicalTrials.gov registry entry for NCT02475031 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (70% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which TAP-C is the first listed.
NCT02475031 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT02475031 about?
NCT02475031 is a clinical study titled "Single-shot TAP Block vs Continuous TAP Block". The purpose of this study is to determine whether continuous transversus abdominis plane (TAP) block is superior to single shot TAP for postoperative pain after laparoscopic donor nephrectomy
What is the current status of trial NCT02475031?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2012-07. Estimated completion is 2015-12.
What conditions does trial NCT02475031 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT02475031?
The interventions under investigation include: TAP-C (DEVICE), TAP-S (DRUG).
Who is sponsoring clinical trial NCT02475031?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02475031 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
ACTIVE NOT RECRUITING · Phase 4
-
Pain Control With Total Knee Replacement
COMPLETED · Phase 4
-
Intrathecal Morphine for Cesarean Delivery
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.